US Medical Affairs, Lung Cancer Evidence & Strategy Intern

AstraZeneca • Gaithersburg, MD

18h • Onsite

About The Position

This 12-week internship will be based at the company’s Gaithersburg, Maryland site from May 24, 2027, through August 13, 2027. The intern will review the evolving lung cancer evidence landscape, focusing on EGFR-mutated non-small cell lung cancer, emerging therapies, clinical trials, biomarkers, and other scientific developments relevant to U.S. Medical Affairs. The role involves analyzing and synthesizing clinical trial results, scientific literature, and major oncology congress updates to identify treatment trends, evidence gaps, and scientific questions that may affect future lung cancer management. The intern will also develop and maintain an integrated evidence and competitive landscape to support Medical Affairs planning. The position requires onsite work in Gaithersburg three days per week and does not provide relocation assistance. Applicants must have an expected graduation date after August 2027 and U.S. work authorization at the time of application; CPT support will not be provided. Compensation is $35–$48 per hour.

Requirements

• Be a PharmD- or Master’s-level student studying Pharmaceutical Sciences, Biostatistics, Epidemiology/Public Health, Data Science, Biomedical Sciences, Cancer Biology, Pharmacology, Translational Medicine, or a related life-sciences discipline.
• Have a strong interest in oncology, clinical research, Medical Affairs, or evidence generation.
• Have strong analytical, written, and verbal communication skills, including the ability to clearly summarize complex scientific information.
• Have an expected graduation date after August 2027.
• Have U.S. work authorization at the time of application; CPT support is not available.
• Be able to report onsite to the Gaithersburg, Maryland site three days per week.

Nice To Haves

• Ability to critically review and synthesize scientific literature and clinical trial data.
• Experience conducting literature reviews, evidence synthesis, research projects, or scientific presentations.
• Coursework or academic experience in pharmacy, epidemiology, biostatistics, public health, biomedical sciences, clinical research, or a related discipline.
• Exposure to clinical trial design, interpretation of efficacy and safety endpoints, or basic statistical concepts.
• Ability to work independently on a defined project while collaborating effectively with cross-functional stakeholders.
• Proficiency with Microsoft Excel and PowerPoint.
• Experience with data visualization or analytical tools such as Power BI, R, Python, or similar platforms.

Responsibilities

• Conduct structured reviews of the evolving lung cancer evidence landscape, particularly EGFR-mutated non-small cell lung cancer, emerging therapies, clinical trials, biomarkers, and related scientific developments.
• Analyze and synthesize clinical trial results, scientific literature, and major oncology congress updates.
• Identify emerging treatment trends, evidence gaps, and scientific questions that may affect future lung cancer management.
• Develop and maintain an integrated evidence and competitive landscape covering key clinical trials, treatment approaches, relevant endpoints and patient populations, upcoming data readouts, and other scientific developments.
• Support Medical Affairs planning with evidence and competitive landscape analyses.

What This Job Offers

• Job Type: Full-time
• Career Level: Intern